Next Article in Journal
Impacts of Traverse Speed and Material Thickness on Abrasive Waterjet Contour Cutting of Austenitic Stainless Steel AISI 304L
Previous Article in Journal
Computational Modeling of Ultrasound C-Scan Imaging Using Transmitted Signal Peak Density
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Streptomyces Isolates from the Soil of an Ancient Irish Cure Site, Capable of Inhibiting Multi-Resistant Bacteria and Yeasts

1
Centre for Molecular Biosciences, Ulster University, Coleraine BT52 1SA, N. Ireland, UK
2
Department of Biotechnology, College of Science, University of Diyala, Baqubah 32001, Iraq
3
Department of Orthopaedics, Altnagelvin Hospital, Londonderry BT47 6SB, N. Ireland, UK
4
Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia
5
Institute of Life Sciences, Medical School, Swansea University, Singleton Park, Swansea SA2 8PP, Wales, UK
6
Instituto de Biologia, Rua Outeiro de São João Batista, s/nº Campus do Valonguinho, Universidade Federal Fluminense, Niterói 24210-130, Brazil
7
IBERS, Aberystwyth University, Penglais, Aberystwyth, Ceredigion SY23 3EE, Wales, UK
*
Author to whom correspondence should be addressed.
Appl. Sci. 2021, 11(11), 4923; https://doi.org/10.3390/app11114923
Submission received: 7 May 2021 / Revised: 24 May 2021 / Accepted: 25 May 2021 / Published: 27 May 2021
(This article belongs to the Section Applied Biosciences and Bioengineering)

Abstract

:
Traditional Irish medicines are often intertwined with ritual and spirituality, making it difficult to substantiate the validity of their claims. In this manuscript, we use molecular and microscopic techniques to investigate some microorganisms that might be responsible for the reputed healing properties of an ancient Irish soil cure known as the Blessed clay from a site in Boho in the West Fermanagh Scarplands. We previously reported the isolation of an antibiotic producing bacteria from this soil. In this report, we characterize the antibiotic activity of a further six isolates of Streptomyces from this source. Two of these isolates inhibit the growth of multi-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa, two inhibit the growth of the yeast Starmerella bombicola, and two have as yet undetermined activity. Genetic analysis of these Streptomyces reveals the potential to synthesize varieties of antibiotics similar to cypemycin, griseochelin, macrolactams, and candicidin. From these observations, we suggest that part of the medicinal reputation of the Blessed clay may lie in the diversity of antimicrobial producing Streptomyces isolated from this soil. These findings highlight the potential for antibiotic discovery in this area.

Graphical Abstract

1. Introduction

The record of traditional Irish folk medicine, essentially passed on by word of mouth, is fading from the living landscape. The principal reasons for this are the advancing age of the population, the sharp decline in the use of traditional medicine, and of course, the reliability of modern medicines. However, in a reversal of fortune, researchers are now looking towards traditional medicines as a potential source of new pharmaceutical compounds [1,2,3,4,5].This necessity is partly due to a reduction in the supply of new antibiotics caused by years of under-investment [6,7]. Indeed, the World Health Organization (WHO), in their Global Pathogen Priority (GPP) catalogue, identified a group of multi-resistant pathogens, including methicillin resistant Staphylococcus aureus and multi resistant Pseudomonas aeruginosa, as priority targets for the research and development of new antibiotics [8]. These challenges have prompted researchers to pursue more innovative methods of drug discovery. One of these approaches, pioneered by Geoffrey Cordell, was the analysis of traditional folk-medicine. Geoffrey discovered that traditional medicines yielded far more successful lead compounds in the development of anticancer drugs than random plant screenings [9]. These ideas were quickly adopted by other researchers. Pioneering work by the group of Julian Davies in British Columbia discovered that the sacred clay, used for millennia by the Heiltsuk peoples of Kisameet Bay, was able to combat many multi-resistant hospital pathogens [3]. In another part of the globe, researchers in Jordan attributed the therapeutic activity of ‘Red clay’ to a high proportion of antibiotic producing bacteria found in the soil [10]. Researchers have discovered that antibiotic producing organisms could also have a close relationship with plants. This was the case for Streptomyces sp. strain Y3111, which lives in association with the traditional Chinese medicinal plant Heracleum souliei and produces anti-tubercular (anti-BCG) compounds named heraclemycins [1]. Some researchers have even reconstituted ancient medicines from old texts that have been proven to be effective against antibiotic resistant organisms such as methicillin resistant Staphylococcus aureus (MRSA) [2]. The common theme running through many of these discoveries has been the presence of Streptomyces. Together with other closely related genera, these organisms produce as much as 50% of the world’s current antibiotics, as well as anticancer, antiparasitic, and antifungal compounds [11].
The West Fermanagh Scarplands are a remote range of limestone hills on the border between N. Ireland and Eire. This area has a long tradition of folk cures associated with rocks, soils, and wells, some of which are named after the diseases they cure, such as jaundice, scurvy, and ague. One of the traditional medicines from this area concerns the soil that covers the grave of a cleric known as Fr McGirr. Fr McGirr belonged to a group of priests who emerged at the end of the penal laws in Ireland. Many of these people were familiar with both spirituality and local folk healing practices [12]. In his later years’ Fr McGirr stated that the soil that covered him would be able to cure the same diseases as it did when he was alive. This soil or ‘Blessed clay’, as it is described by locals, is wrapped in cloth and is given for ailments as diverse as toothache or tuberculosis. In our previous research, we isolated one species of Streptomyces from this soil that inhibited several antibiotic resistant pathogens [13]. Our current investigation involves the isolation and characterization of other Streptomycetes isolated from this soil. We also used the antibiotic prediction software antiSMASH [14,15], in combination with in vitro antimicrobial analysis, to optimize the potential antimicrobial identification from the genomes of these isolates.

2. Materials and Methods

2.1. Microorganism Strains

Methicillin resistant Staphylococcus aureus (MRSA) (ATCC 43300), Pseudomonas aeruginosa (PA01), and Starmerella bombicola were kindly provided by Prof. I.M. Banat (Ulster University). Streptomyces sp. myrophorea isolate McG1 (NCTC 14177, DSM 107716) was previously isolated from a soil sample in the Boho region of the West Fermanagh Scarplands and is also referred to as Streptomyces strain McG1 in this manuscript [13].
Streptomyces isolates McG2 up to McG7 were also isolated from the same soil sample, as described above. One gram of this soil sample was diluted in 1 mL sterile water, vortexed, and cultured on International Streptomyces Project (ISP) 2 agar (1/5th strength) and starch agar (Oxoid, Hampshire, UK), as previously described [13]. Streptomyces isolates were characterized by observing their distinctive colony morphology (small, embedded colonies with powdery surfaces) on ISP2 media. These species were further identified using whole genome sequencing. Stocks of these Streptomyces were frozen at –80 °C in 18% glycerol after their initial isolation.

2.2. Antimicrobial Tests

Antimicrobial tests followed a modified agar overlay method [16]. Briefly, an agar plug/core of Streptomyces that had grown on soy flour mannitol (SFM) agar for 9–15 days was placed within wells made in 15 mL of 1.5% agar. This was overlaid with Muller–Hinton agar containing pre-diluted test organism at 42 °C in the case of P. aeruginosa, tryptic soy agar (TSB) in the case of S. aureus, and Sabouraud dextrose agar in the case of S. bombicola. In cases where the overlay methods were not consistent, a sterile swab was used to apply a dilution of 1 × 106 cfu/mL of test organism. Zones of inhibition in the confluent growth of test pathogens was deemed to indicate antimicrobial activity. Inhibition zones less than 1mm from agar core were recorded as resistant.
Antibiograms followed the Kirby–Bauer protocol [17]. Organisms were grown on Muller–Hinton agar and tested against a variety of antibiotic discs, which were placed on top of the agar. Agar plates were incubated overnight at 37 °C. The presence of a zone of inhibition greater than 1 mm from the edge of the disk indicated inhibition.

2.3. Molecular Biology

2.3.1. Genome Sequencing

Genome sequencing of Streptomyces was performed by MicrobesNG (Birmingham, UK). The DNA was extracted from Streptomyces using a Qiagen DNA extraction Kit 200 (Qiagen, Venlo, The Netherlands) with modifications. A pure culture of Streptomyces grown on an agar plate was suspended in 500 mL PBS in lysing matrix in a 2 mL tube (MP biomedical, Santa Ana, CA, USA). Bacterial cells were lysed by fast prep (60 for 40 s (×2). The suspension was centrifuged, and the supernatant was transferred to 2 mL Eppendorf tubes. Next, 500 µL of ATL lysis buffer and 80 µL of proteinase were added and incubated for 10 min at 70 °C. A further 16 µL RNase and 500 µL were then added to the buffer and incubated at 70 °C for 7 min. A further 600 µL of ethanol was then added. The suspension was transferred to the mini spin column and centrifuged at 6010× g for 1 min. This step was repeated until the whole suspension had passed through. The column was washed twice, and the DNA was eluted in 50 µL of elution buffer. Extracted DNA was quantified with a Nano Drop spectrophotometer.
Genomic DNA libraries were prepared using Nextera XT Library Prep Kit (Illumina, San Diego, CA, USA). The manufacturers protocol was changed slightly by adding two nanograms of DNA instead of one as an input, and the PCR elongation time was changed from 30 s to one minute. DNA quantification and library preparation were performed on a Hamilton Microlab STAR automated liquid handling system. Pooled libraries were quantified using the Kapa Biosystems Library Quantification Kit for Illumina on a Roche light cycler 96 qPCR machine. Libraries were sequenced on the Illumina HiSeq using a 250 bp paired end protocol. Reads were adapter trimmed using Trimmomatic 0.30 with a sliding window quality cut off of Q15 [18]. De novo assembly was performed on samples using SPAdes version 3.7 [19], and contigs were annotated using Prokka 1.11 [20].The genomes of Streptomyces spp. isolates McG2, McG3, McG5, McG6, McG7, and McG8 were sequenced. The sequence of Streptomyces sp. isolate McG1 was already reported in another study [13].

2.3.2. Genome Deposition

Whole genome sequences of Streptomyces spp. isolates McG2, McG3, McG5, McG6, McG7, McG8 were deposited in DDBJ/ENA/GenBank in the Bioproject PRJNA433829 under the following accession numbers: McG2, JAAXYB000000000; McG3, JAAXYC000000000; McG5: JAAXYD000000000; McG6, JAAXYE000000000; McG7, JAAXYF000000000; and McG8, JAAXYG000000000. The versions described here are the first versions and have been assembled to the contig level.

2.3.3. Taxonomic Position of Streptomyces Isolates Using a Maximum-Likelihood Phylogeny

A multi-locus phylogeny was reconstructed by the method reported previously [13]. Briefly, whole genome sequences (WGS) for all Streptomyces were retrieved autonomously from GenBank. Genomes were annotated in PROKKA [20], and the resulting translated coding domain sequences were used to generate a multi-locus, concatenated alignment of 400 proteins in PhyloPhlan [21]. Proteins used for the alignment were those shown to be conserved among bacterial genera [21]. A maximum-likelihood phylogeny was reconstructed in FastTree and rendered in iTOL [22,23]. The robustness of the phylogeny was assessed using 1000 bootstrap replications. The phylogeny was reconstructed with 921 Streptomyces genomes (including McG designated isolates). The phylogeny was outgroup rooted along the lineage leading to Frankia (five species). The full list of species in the phylogeny can be found in Supplementary Data (File S1). Genome-to-genome distance calculations were performed in GGDC web server (http://ggdc.dsmz.de/ server accessed on 22 May 2021) using formula 3 to account for the use of draft genomes.

2.3.4. Secondary Metabolite Analysis

Gene clusters known to be involved in secondary metabolite biosynthesis, self-immunity, or resistance were identified using Antibiotics and Secondary Metabolite Analysis Shell (anti-SMASH) version 4.0.0 [14]. The relaxed metabolite matching parameter in antiSMASH was chosen for comparison of the Streptomyces genomes. This detects well-defined clusters containing all required parts of a biosynthetic gene cluster, as well as partial clusters missing one or more functional parts. The GenBank sequence files (from Prokka annotation) were submitted to the web interface selecting all extra features of annotation.

3. Results

3.1. Microbial Characterization

We isolated six Streptomyces from the ‘Blessed clay’ of Fr McGirr, which we labelled as Streptomyces spp. McG2 to McG8 (herein referred to as McG2 to McG8). These were identified from colony morphology, microscopy, and whole genome sequencing. We have previously characterized Streptomyces sp. myrophorea isolate McG1 (NCTC 14177) [13].
Streptomyces spp. McG2 to McG8 grew well on ISP2, PDA, and starch agar. All isolates were characterized by small, embedded colonies with powdery surfaces that emitted earthy odors. All of these Streptomyces isolates had a high salt (NaCl) tolerance (Table 1).
Microscopically, all Streptomyces isolates were Gram-positive, filamentous, with branching and aerial hyphae that produced spores.

3.2. Antimicrobial Activities of the Isolated Streptomyces Strains

The antimicrobial activity of the Streptomyces isolates was tested against methicillin resistant Staphylococcus aureus (MRSA) (ATCC 43300), Pseudomonas aeruginosa (PA 01), and the yeast Starmerella bombicola on agar plates using a modified version of the Lehrer assay (Figure 1 and Table 2). The antibiotic resistance profiles of the test organisms are shown in Table 3.

3.3. Genome Assembly of Streptomyces Isolates from the Boho Clay

Streptomyces genomes were assembled de-novo by MicrobesNG (Birmingham University, Birmingham, UK). The k-mer spectrums of contigs larger than 2000 bp were calculated based on an approach described previously [24]. For four of the isolates, sets of low coverage contigs with k-mer spectrums significantly different from the five largest contigs in the assembly were identified as probable contaminants. All small contigs of less than 500 bp were removed from the assemblies (Table 4).

3.4. Prediction of Antibiotic Gene Cluster Similarities

The potential of the Streptomyces isolates to produce antibiotics and other secondary metabolites was predicted using antiSMASH (version 4), which compared our unknown gene sequences with previously documented antibiotic/secondary metabolite biosynthetic gene clusters (BGC). These BGCs contain the genes necessary to produce secondary metabolites, including enzymes and pathway-specific regulatory genes.
We identified many BCGs in the genomes of the six strains of Streptomyces from the Blessed clay using antiSMASH. Many of the gene cluster similarities identified are common in Streptomyces, including albaflavenone (a sesquiterpene antibiotic) [25], alkylresorcinol [26], desferrioxamine (a siderophore that mitigates cytotoxicity to doxorubicin) [27], ectoine [28], isorenieratene (a bacterial chlorophyll) [29], and melanin [30]. These compounds are recorded here because of their potential synergy with antibiotics [31]. Most importantly, there were also similarities between the gene sequences we identified in these Streptomyces and several antibiotic gene synthesis clusters, including those for polycyclic tetramate macrolactams (SGR PTM), candicidin, griseochelin, cypemycin, and cyslabdan [31,32,33,34,35] (Table 5).
AntiSMASH identified several gene clusters in whole genome sequences of Streptomyces isolates McG1 and McG5 with similarities to the lantibiotic cypemycin (77%) (Figure 2a).
Genes from Streptomyces sp. McG3 showed similarities to the griseochelin (zincophorin) biosynthesis cluster (Figure 2b). Boho Streptomyces sp. isolates McG1 and McG3 had similar gene sequences to biosynthesis clusters for SGR PTM, a polytetramic macrolactam [36] (Figure 2c). Streptomyces strains McG2, 5, and 6 had gene similarities to biosynthesis clusters for candicidin, an antifungal antibiotic [37] (Figure 2d). Finally, the WGS of Streptomyces isolates McG7 and McG8 showed similarities to gene clusters for cyslabdan [32].

3.5. Streptomyces Isolate Phylogeny

The relationships between the Streptomyces isolates from the Boho clay were calculated using the maximum-likelihood of relatedness. This placed isolates McG2, McG5, and McG6 alongside the S. albidoflavus clade, suggesting that these were likely variants (Figure 3a). Indeed, GGDC calculations supported this, showing that isolates McG2, McG5, and McG6 were closely related to other S. albidoflavus strains with DDH scores of 90, 94, and 90, respectively. Moreover, probability scores of being the same species (i.e., S. albidoflavus) being >99% in all cases. Phylogenetically, Streptomyces isolate McG3 (Figure 3b) sits alongside Streptomyces sp. CNB-091, a marine Streptomyces [38].
The closest species to Streptomyces sp. McG7 and McG8 was Streptomyces sp. FxanaD5 (Figure 3c). These new isolates were added to the data set of [5,13]. The full phylogeny is available from the authors on request.

4. Discussion

There has been an increasing interest in the potential of traditional medicines to provide new medicines over the past few decades [3]. However, many of the older tradition medicines are hard to decipher because of their complicated relationship with rituals and mythology. Using a series of microbiological methods, we isolated a group of Streptomyces from the Blessed clay of Fr McGirr in the West Fermanagh Scarplands. Several of these isolates inhibited the growth of multi-resistant pathogens and yeasts. These add to the growing list of Streptomyces sp. isolated from traditional medicines that are able to produce antibiotics against fungi and bacteria [39]. We were also able to predict the potential synthesis of a variety of antimicrobial substances from these isolates. We think that these discoveries may provide a possible explanation as to why this soil has historically been used as a folk medicine. There is also the possibility that other types of bacteria could also be associated with the reputed antimicrobial activity of this soil; however, in this study we concentrated solely on Streptomyces. Additionally, the activity of the Blessed clay could equally be based on some type of clay mineral, such as Montmorillonite [40,41] or sulfur- and iron-reducing bacteria [42]. However, the Blessed clay in this study has a silty-loam consistency rather than clay-like, similar to the rest of the soil found in this area.
Given the continuous spiritual significance of this site, we assume many of the folk medicines found in this area are derived from much older cultures. Since this particular traditional soil medicine was passed down by word of mouth, we are still uncertain of the conditions under which it could yield its full therapeutic potential. Therefore, even though we managed to induce the production of antibiotics from Streptomyces isolated from this soil under laboratory conditions, this might still not be the complete repertoire of its activity.
We are aware that limestone areas similar to Boho have long been regarded as a rich source of antibiotic producing Streptomyces [43,44,45]. The Streptomyces species identified from the Blessed clay sample is grouped into three main clusters. Streptomyces spp. McG7 and McG8 were found to be closely related to both Streptomyces sp. FxanaD5 and S. griseorubens JSD-1. Streptomyces sp. isolate McG3 was found to be closely related to Streptomyces sp. CNB-091, a marine Streptomyces 38]; S. griseus subsp griseus NRRL B 2682; and Streptomyces sp. McG1 (Streptomyces sp. myrophorea) [13]. In the last grouping, Streptomyces spp. isolates McG2, McG5, and McG6 were closely related to S. albidoflavus. In many cases, these Boho Streptomyces isolates were closely related to marine species.
In terms of antibiotic potential of the Boho clay isolates, antiSMASH software predicted that Streptomyces isolates McG2, McG5, and McG6 had biosynthetic gene clusters similar to those for candicidin, an antifungal compound [37]. It has been reported that the majority of isolates exclusively producing candicidin come mainly from which matches with the identity of Streptomyces sp. isolates McG2, McG5, and McG6 [46]. However, our in vitro inhibition tests showed that only Streptomyces isolates McG5 and McG6 expressed anti-fungal activities, whilst McG2 did not show any activity.
In vitro testing showed that only Streptomyces isolates McG1, McG2, and McG3 had any inhibitory effect on multi-resistant bacteria. The identities of the compounds responsible for this activity were difficult to discern from the antiSMASH predictions since there were several biosynthetic gene clusters identified for each isolate. Streptomyces isolates McG1 and McG3 encoded antibiotic synthesis clusters similar to Streptomyces griseus polytetramic macrolactam (SGR PTM), an antifungal and antioxidant [36]. Streptomyces isolates McG1 and McG3 also encoded gene synthesis clusters similar to those of griseochelin (zincophorin), a carboxylic acid antibiotic that is active against Gram-positive bacteria and viruses. Streptomyces isolates McG1 and McG5 also have gene synthesis clusters for cypemycin, a Gram-positive antibiotic that also has activity against leukemia [34]. Finally, a gene cluster from Streptomyces isolates McG7 and McG8 showed similarity to those previously identified for the synthesis of cyslabdan, an antimicrobial potentiator [33]. Several researchers have also shown that some species of Streptomyces that only produce low levels of antibiotic when cultivated alone are able to induce other species to express new antibiotics [47]. This may be an interesting direction to follow in future research.
Altogether, the Streptomyces species isolated here are effective against multi-resistant bacteria and fungi. It may be possible that this spectrum might extend to anticancer and antiviral activity, but this is still the subject of ongoing research. This new source of Streptomyces strains may be a useful resource in helping to replenishing the ever-decreasing range of antibiotics capable of combating multi-resistant microbial pathogens.

5. Conclusions

We identified a group of Streptomyces from the Blessed clay in the Boho region of West Fermanagh. We have shown through genome analysis and by in vitro tests that some of these Streptomyces have the ability to produce antimicrobial compounds that inhibit the growth of clinically significant multi-resistant pathogens in vitro. We do not know how to activate this soil in situ, but we feel that the abundance of Streptomyces discovered in the Boho clay might be responsible for its reputed healing abilities. We think that these findings might provide a basis for future antibiotic discovery.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/app11114923/s1, File S1: List of species used in taxonomic positioning of Streptomyces isolates using a maximum-likelihood phylogeny analysis.

Author Contributions

Author Contributions: Conceptualization, G.A.Q., M.T.S., P.D.F. and I.M.B.; data curation, A.M.A., N.K.A., L.M.B., M.T.S., D.C. and P.D.F.; formal analysis, G.A.Q., A.M.A., N.K.A., D.C., S.A.A., L.M.B., P.D.F., M.T.S., A.M.B. and L.T.; funding acquisition, G.A.Q., N.K.A., H.C.C. and P.J.D.; investigation, G.A.Q., D.C., S.A.A., M.T.S., H.C.C., P.D.F., L.M.B. and L.T.; methodology, G.A.Q., A.M.A., H.C.C., P.D.F., L.M.B. and L.T.; resources, D.C., I.M.B., H.C.C., P.J.D. and P.D.F.; software, A.M.A., N.K.A., M.T.S., P.D.F. and L.M.B.; supervision, G.A.Q., I.M.B., H.C.C. and P.J.D.; validation, M.T.S., P.D.F., A.M.B. and L.M.B.; visualization, G.A.Q., P.D.F. and L.M.B.; writing—original draft, G.A.Q., A.M.A., N.K.A., D.C., S.A.A., M.T.S., H.C.C., P.D.F., L.T. and I.M.B.; writing—review and editing, G.A.Q., L.T., A.M.A., A.M.B., N.K.A., D.C., P.J.D., S.A.A., M.T.S., H.C.C., P.D.F. and I.M.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financed through the kind donations of time and equipment by colleagues in Ulster University, Swansea University, The Ruder Boskovic Institute, and Crowd.science contributions from Julie Martellini, Helena Bilandzija, Lidia Vila, Vera Alexandra, Zepur Agopyan, Marijana Bakovifa, and Janette Baldrick.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Permissions

Permissions for sampling the soil were obtained verbally and by email from the relevant authorities.

Data Availability Statement

All datasets generated or analyzed for this study are included in the manuscript and the Supplementary Materials. The data for the six genomes of Streptomyces spp. isolates were deposited at DDBJ/ENA/GenBank in the Bioproject PRJNA433829.

Acknowledgments

We are extremely grateful for the help of the custodians of the lands around the area of West Fermanagh, Jimmy McPhillips and Cahal Deery, staff at the Ruder Boskovic Institute, technical assistance from Daniel McShane, and invaluable knowledge of local traditions from the Boho area from M McGurn and B. Quinn.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Liu, M.; Abdel-Mageed, W.M.; Ren, B.; He, W.; Huang, P.; Li, X.; Bolla, K.; Guo, H.; Chen, C.; Song, F.; et al. Endophytic Streptomyces Sp. Y3111 from Traditional Chinese Medicine Produced Antitubercular Pluramycins. Appl. Microbiol. Biotechnol. 2014, 98, 1077–1085. [Google Scholar] [CrossRef] [PubMed]
  2. Harrison, F.; Roberts, A.E.L.; Gabrilska, R.; Rumbaugh, K.P.; Lee, C.; Diggle, S.P. A 1000-Year-Old Antimicrobial Remedy with Antistaphylococcal Activity. mBio 2015, 6. [Google Scholar] [CrossRef] [PubMed]
  3. Behroozian, S.; Svensson, S.L.; Davies, J. Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens. mBio 2016, 7. [Google Scholar] [CrossRef] [PubMed]
  4. Wagner, C.S.; De Gezelle, J.; Robertson, M.; Robertson, K.; Wilson, M.; Komarnytsky, S. Antibacterial Activity of Medicinal Plants from The Physicians of Myddvai, a 14th Century Welsh Medical Manuscript. J. Ethnopharmacol. 2017, 203, 171–181. [Google Scholar] [CrossRef]
  5. Quinn, G.A.; Abdelhameed, A.M.; Alharbi, N.K.; Cobice, D.; Adu, S.A.; Swain, M.T.; Castro, H.C.; Facey, P.D.; Bakshi, H.A.; Tambuwala, M.M.; et al. The Isolation of a Novel Streptomyces Sp. CJ13 from a Traditional Irish Folk Medicine Alkaline Grassland Soil That Inhibits Multiresistant Pathogens and Yeasts. Appl. Sci. 2021, 11, 173. [Google Scholar] [CrossRef]
  6. Kapoor, G.; Saigal, S.; Elongavan, A. Action and Resistance Mechanisms of Antibiotics: A Guide for Clinicians. J. Anaesthesiol. Clin. Pharmacol. 2017, 33, 300–305. [Google Scholar] [CrossRef]
  7. Ribeiro da Cunha, B.; Fonseca, L.P.; Calado, C.R.C. Antibiotic Discovery: Where Have We Come from, Where Do We Go? Antibiotics 2019, 8, 45. [Google Scholar] [CrossRef]
  8. Tacconelli, E.; Carrara, E.; Savoldi, A.; Harbarth, S.; Mendelson, M.; Monnet, D.L.; Pulcini, C.; Kahlmeter, G.; Kluytmans, J.; Carmeli, Y.; et al. Discovery, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis. Lancet Infect. Dis. 2018, 18, 318–327. [Google Scholar] [CrossRef]
  9. Cordell, G.A.; Farnsworth, N.R.; Beecher, C.W.W.; Doel Soejarto, D.; Kinghorn, A.D.; Pezzuto, J.M.; Wall, M.E.; Wani, M.C.; Cobb, R.R.; O’Neill, M.J.; et al. Novel Strategies for the Discovery of Plant-Derived Anticancer Agents. In Anticancer Drug Discovery and Development: Natural Products and New Molecular Models. Developments in Oncology; Valeriote, F.A., Baker, L.H., Eds.; Springer: Boston, MA, USA, 1994; ISBN 978-1-4613-6118-3. [Google Scholar]
  10. Falkinham, J.O., 3rd; Wall, T.E.; Tanner, J.R.; Tawaha, K.; Alali, F.Q.; Li, C.; Oberlies, N.H. Proliferation of Antibiotic-Producing Bacteria and Concomitant Antibiotic Production as the Basis for the Antibiotic Activity of Jordan’s Red Soils. Appl. Environ. Microbiol. 2009, 75, 2735–2741. [Google Scholar] [CrossRef]
  11. Antoraz, S.; Santamaría, R.I.; Díaz, M.; Sanz, D.; Rodríguez, H. Toward a New Focus in Antibiotic and Drug Discovery from the Streptomyces Arsenal. Front. Microbiol. 2015, 6, 461. [Google Scholar] [CrossRef]
  12. Donnelly, C.J. Masshouses and Meetinghouses: The Archaeology of the Penal Laws in Early Modern Ireland. Int. J. Hist. Archaeol. 2004, 8, 119–132. [Google Scholar] [CrossRef]
  13. Terra, L.; Dyson, P.J.; Hitchings, M.D.; Thomas, L.; Abdelhameed, A.; Banat, I.M.; Gazze, S.A.; Vujaklija, D.; Facey, P.D.; Francis, L.W.; et al. A Novel Alkaliphilic Streptomyces Inhibits ESKAPE Pathogens. Front. Microbiol. 2018, 9, 2458. [Google Scholar] [CrossRef] [PubMed]
  14. Medema, M.H.; Blin, K.; Cimermancic, P.; de Jager, V.; Zakrzewski, P.; Fischbach, M.A.; Weber, T.; Takano, E.; Breitling, R. AntiSMASH: Rapid Identification, Annotation and Analysis of Secondary Metabolite Biosynthesis Gene Clusters in Bacterial and Fungal Genome Sequences. Nucleic Acids Res. 2011, 39, W339–W346. [Google Scholar] [CrossRef] [PubMed]
  15. Adamek, M.; Spohn, M.; Stegmann, E.; Ziemert, N. Mining Bacterial Genomes for Secondary Metabolite Gene Clusters. Methods Mol. Biol. 2017, 1520, 23–47. [Google Scholar] [CrossRef]
  16. Lehrer, R.I.; Rosenman, M.; Harwig, S.S.; Jackson, R.; Eisenhauer, P. Ultrasensitive Assays for Endogenous Antimicrobial Polypeptides. J. Immunol. Methods 1991, 137, 167–173. [Google Scholar] [CrossRef]
  17. Bauer, A.W.; Kirby, W.M.; Sherris, J.C.; Turck, M. Antibiotic Susceptibility Testing by a Standardized Single Disk Method. Am. J. Clin. Pathol. 1966, 45, 493–496. [Google Scholar] [CrossRef]
  18. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 2014, 30, 2114–2120. [Google Scholar] [CrossRef]
  19. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.; Pham, S.; Prjibelski, A.D.; et al. SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 2012, 19, 455–477. [Google Scholar] [CrossRef]
  20. Seemann, T. Prokka: Rapid Prokaryotic Genome Annotation. Bioinformatics 2014, 30, 2068–2069. [Google Scholar] [CrossRef]
  21. Segata, N.; Börnigen, D.; Morgan, X.C.; Huttenhower, C. PhyloPhlAn Is a New Method for Improved Phylogenetic and Taxonomic Placement of Microbes. Nat. Commun. 2013, 4, 2304. [Google Scholar] [CrossRef]
  22. Price, M.N.; Dehal, P.S.; Arkin, A.P. FastTree 2--Approximately Maximum-Likelihood Trees for Large Alignments. PLoS ONE 2010, 5. [Google Scholar] [CrossRef]
  23. Letunic, I.; Bork, P. Interactive Tree of Life (ITOL) v3: An Online Tool for the Display and Annotation of Phylogenetic and Other Trees. Nucleic Acids Res. 2016, 44, W242–W245. [Google Scholar] [CrossRef]
  24. Swain, M.T. Fast Comparison of Microbial Genomes Using the Chaos Games Representation for Metagenomic Applications. Procedia Comput. Sci. 2013, 18, 1372–1381. [Google Scholar] [CrossRef]
  25. Gurtler, H.; Pedersen, R.; Anthoni, U.; Christophersen, C.; Nielsen, P.H.; Wellington, E.M.; Pedersen, C.; Bock, K. Albaflavenone, a Sesquiterpene Ketone with a Zizaene Skeleton Produced by a Streptomycete with a New Rope Morphology. J. Antibiot. 1994, 47, 434–439. [Google Scholar] [CrossRef]
  26. Kanda, N.; Ishizaki, N.; Inoue, N.; Oshima, M.; Handa, A. DB-2073, a New Alkylresorcinol Antibiotic. I. Taxonomy, Isolation and Characterization. J. Antibiot. 1975, 28, 935–942. [Google Scholar] [CrossRef]
  27. Challis, G.L.; Hopwood, D.A. Synergy and Contingency as Driving Forces for the Evolution of Multiple Secondary Metabolite Production by Streptomyces Species. Proc. Natl. Acad. Sci. USA 2003, 100, 14555. [Google Scholar] [CrossRef]
  28. Galinski, E.A.; Pfeiffer, H.P.; Truper, H.G. 1,4,5,6-Tetrahydro-2-Methyl-4-Pyrimidinecarboxylic Acid. A Novel Cyclic Amino Acid from Halophilic Phototrophic Bacteria of the Genus Ectothiorhodospira. Eur. J. Biochem. 1985, 149, 135–139. [Google Scholar] [CrossRef]
  29. Krugel, H.; Krubasik, P.; Weber, K.; Saluz, H.P.; Sandmann, G. Functional Analysis of Genes from Streptomyces Griseus Involved in the Synthesis of Isorenieratene, a Carotenoid with Aromatic End Groups, Revealed a Novel Type of Carotenoid Desaturase. Biochim. Biophys. Acta 1999, 1439, 57–64. [Google Scholar] [CrossRef]
  30. El-Naggar, N.E.-A.; El-Ewasy, S.M. Bioproduction, Characterization, Anticancer and Antioxidant Activities of Extracellular Melanin Pigment Produced by Newly Isolated Microbial Cell Factories Streptomyces Glaucescens NEAE-H. Sci. Rep. 2017, 7, 42129. [Google Scholar] [CrossRef]
  31. Gokarn, K.; Pal, R.B. Activity of Siderophores against Drug-Resistant Gram-Positive and Gram-Negative Bacteria. Infect. Drug Resist. 2018, 11, 61–75. [Google Scholar] [CrossRef]
  32. Koyama, N.; Tokura, Y.; Münch, D.; Sahl, H.-G.; Schneider, T.; Shibagaki, Y.; Ikeda, H.; Tomoda, H. The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of β-Lactams against MRSA by Inhibiting Pentaglycine Interpeptide Bridge Synthesis. PLoS ONE 2012, 7. [Google Scholar] [CrossRef]
  33. Fukumoto, A.; Kim, Y.-P.; Matsumoto, A.; Takahashi, Y.; Shiomi, K.; Tomoda, H.; Ōmura, S. Cyslabdan, a New Potentiator of Imipenem Activity against Methicillin-Resistant Staphylococcus Aureus, Produced by Streptomyces Sp. K04-0144. J. Antibiot. 2008, 61, 1–6. [Google Scholar] [CrossRef]
  34. Claesen, J.; Bibb, M. Genome Mining and Genetic Analysis of Cypemycin Biosynthesis Reveal an Unusual Class of Posttranslationally Modified Peptides. Proc. Natl. Acad. Sci. USA 2010, 107, 16297. [Google Scholar] [CrossRef]
  35. Grafe, U.; Schade, W.; Roth, M.; Radics, L.; Incze, M.; Ujszaszy, K. Griseochelin, a Novel Carboxylic Acid Antibiotic from Streptomyces Griseus. J. Antibiot. 1984, 37, 836–846. [Google Scholar] [CrossRef]
  36. Luo, Y.; Huang, H.; Liang, J.; Wang, M.; Lu, L.; Shao, Z.; Cobb, R.E.; Zhao, H. Activation and Characterization of a Cryptic Polycyclic Tetramate Macrolactam Biosynthetic Gene Cluster. Nat. Commun. 2013, 4, 2894. [Google Scholar] [CrossRef]
  37. Jørgensen, H.; Fjaervik, E.; Hakvåg, S.; Bruheim, P.; Bredholt, H.; Klinkenberg, G.; Ellingsen, T.E.; Zotchev, S.B. Candicidin Biosynthesis Gene Cluster Is Widely Distributed among Streptomyces Spp. Isolated from the Sediments and the Neuston Layer of the Trondheim Fjord, Norway. Appl. Environ. Microbiol. 2009, 75, 3296–3303. [Google Scholar] [CrossRef]
  38. Degen, D.; Feng, Y.; Zhang, Y.; Ebright, K.Y.; Ebright, Y.W.; Gigliotti, M.; Vahedian-Movahed, H.; Mandal, S.; Talaue, M.; Connell, N.; et al. Transcription Inhibition by the Depsipeptide Antibiotic Salinamide A. eLife 2014, 3. [Google Scholar] [CrossRef]
  39. Quinn, G.A.; Banat, A.M.; Abdelhameed, A.M.; Banat, I.M. Streptomyces from Traditional Medicine: Sources of New Innovations in Antibiotic Discovery. J. Med. Microbiol. 2020, 69, 1040–1048. [Google Scholar] [CrossRef]
  40. Moosavi, M. Bentonite Clay as a Natural Remedy: A Brief Review. Iran. J. Public Health 2017, 46, 1176–1183. [Google Scholar]
  41. Srasra, E.; Bekri-Abbes, I. Bentonite Clays for Therapeutic Purposes and Biomaterial Design. Curr. Pharm. Des. 2020, 26, 642–649. [Google Scholar] [CrossRef]
  42. Sharma, S.; Grewal, S.; Vakhlu, J. Phylogenetic Diversity and Metabolic Potential of Microbiome of Natural Healing Clay from Chamliyal (J&K). Arch. Microbiol. 2018, 200, 1333–1343. [Google Scholar] [CrossRef] [PubMed]
  43. Yucel, S.; Yamac, M. Selection of Streptomyces Isolates from Turkish Karstic Caves against Antibiotic Resistant Microorganisms. Pak. J. Pharm. Sci. 2010, 23, 1–6. [Google Scholar] [PubMed]
  44. Gosse, J.T.; Ghosh, S.; Sproule, A.; Overy, D.; Cheeptham, N.; Boddy, C.N. Whole Genome Sequencing and Metabolomic Study of Cave Streptomyces Isolates ICC1 and ICC4. Front. Microbiol. 2019, 10, 1020. [Google Scholar] [CrossRef] [PubMed]
  45. Hamedi, J.; Kafshnouchi, M.; Ranjbaran, M. A Study on Actinobacterial Diversity of Hampoeil Cave and Screening of Their Biological Activities. Saudi J. Biol. Sci. 2019, 26, 1587–1595. [Google Scholar] [CrossRef]
  46. Lewis, R.A.; Devi, J.; Green, K.; Li, J.; Hopkins, A.; Hayles, J.; Nurse, P.; Errington, J.; Allenby, N.E.E. Screening and Purification of Natural Products from Actinomycetes That Induce a “Rounded” Morphological Phenotype in Fission Yeast. Nat. Prod. Bioprospect. 2021. [Google Scholar] [CrossRef]
  47. Pishchany, G.; Mevers, E.; Ndousse-Fetter, S.; Horvath, D.J.; Paludo, C.R.; Silva-Junior, E.A.; Koren, S.; Skaar, E.P.; Clardy, J.; Kolter, R. Amycomicin Is a Potent and Specific Antibiotic Discovered with a Targeted Interaction Screen. Proc. Natl. Acad. Sci. USA 2018, 115, 10124. [Google Scholar] [CrossRef]
Figure 1. Boho Streptomyces spp. isolates McG1, McG2, and McG3 tested for inhibitory activity against (a) MRSA 43,300 (b) P. aeruginosa (PA01). Isolates McG5 and McG6 tested for inhibitory activity against (c) S. bombicola. Control wells contain gentamicin (GEN 20 µg), kanamycin (KAN 20 µg), teicoplanin (TE 20 µg), cefoxitin (FOX 20 µg), chlorhexidine (CHG, 40 µg), and control blank (B). Tests performed three or more times.
Figure 1. Boho Streptomyces spp. isolates McG1, McG2, and McG3 tested for inhibitory activity against (a) MRSA 43,300 (b) P. aeruginosa (PA01). Isolates McG5 and McG6 tested for inhibitory activity against (c) S. bombicola. Control wells contain gentamicin (GEN 20 µg), kanamycin (KAN 20 µg), teicoplanin (TE 20 µg), cefoxitin (FOX 20 µg), chlorhexidine (CHG, 40 µg), and control blank (B). Tests performed three or more times.
Applsci 11 04923 g001
Figure 2. Biosynthetic cluster similarities between Streptomyces McG isolates and known antibiotic genes for (a) cypemycin, (b) griseochelin, (c) SGR PTM, and (d) candicidin.
Figure 2. Biosynthetic cluster similarities between Streptomyces McG isolates and known antibiotic genes for (a) cypemycin, (b) griseochelin, (c) SGR PTM, and (d) candicidin.
Applsci 11 04923 g002
Figure 3. Phylogenetic relationships between (a) Streptomyces isolates McG2, McG5, and McG6; (b) Streptomyces isolate McG3; and (c) Streptomyces isolates McG7 and McG8 using maximum-likelihood phylogeny. Phylogenies were reconstructed in FastTree MP and rendered in iTOL.
Figure 3. Phylogenetic relationships between (a) Streptomyces isolates McG2, McG5, and McG6; (b) Streptomyces isolate McG3; and (c) Streptomyces isolates McG7 and McG8 using maximum-likelihood phylogeny. Phylogenies were reconstructed in FastTree MP and rendered in iTOL.
Applsci 11 04923 g003
Table 1. Characterization of Streptomyces isolates from Boho, County Fermanagh.
Table 1. Characterization of Streptomyces isolates from Boho, County Fermanagh.
IsolateColoniesSporesNaCl (w/v) Tolerance in Growth Media
Streptomyces sp. isolate McG1pale green to greengreen to palespores to 6%, grows up to 10%
McG2pale green to greengreen to palegrows and spores up to 10%
McG3pale green to greengreen to palespores to 6%, grows up to 10%
McG5pale green to light brownpale green to browngrows and spores up to 10%
McG6pale green to light brownpale green to browngrows and spores up to 10%
McG7pale green to light brownwhite to brownspores to 8%, grows up to 10%
McG8pale green to light brownbrownspores to 6%, grows up to 10%
Table 2. The inhibitory potential of the Streptomyces isolates from the Boho clay against S. aureus (MRSA 43300), P. aeruginosa (PA01), and S. bombicola. Inhibition zones recorded in millimeters (mm), resistant (R). Tests were repeated a minimum of three times.
Table 2. The inhibitory potential of the Streptomyces isolates from the Boho clay against S. aureus (MRSA 43300), P. aeruginosa (PA01), and S. bombicola. Inhibition zones recorded in millimeters (mm), resistant (R). Tests were repeated a minimum of three times.
IsolateP. aeruginosaS. aureusS. bombicola
Streptomyces sp. isolate McG118.3 ± 0.617.7 ± 0.6R
McG216.5 ± 0.517.3 ± 0.6R
McG319.0 ± 1.020.3 ± 0.6R
McG5RR14.7 ± 2.1
McG6RR11.3 ± 1.5
McG7RRR
McG8RRR
Table 3. The antibiotic resistance profiles of the test organisms S. aureus (MRSA 43300), P. aeruginosa (PA 01), and S. bombicola. Zones of inhibition less than 1 mm from antibiotic disc (Oxoid) were scored as resistant. Antibiotic doses in µg. Resistant (R), not applicable (NA).
Table 3. The antibiotic resistance profiles of the test organisms S. aureus (MRSA 43300), P. aeruginosa (PA 01), and S. bombicola. Zones of inhibition less than 1 mm from antibiotic disc (Oxoid) were scored as resistant. Antibiotic doses in µg. Resistant (R), not applicable (NA).
Antibiotic (µg)S. aureusP. aeruginosaS. bombicola
Teicoplanin 2013.7 ± 0.6NANA
Cefoxitin 20RNANA
Gentamicin 20NA19.3 ± 0.6NA
Kanamycin 20NA21.7 ± 0.6NA
Chlorhexidine 40NANA15.0 ± 1.0
Vancomycin 517.0 ± 1.0RNA
Ampicillin 10RRNA
Ciprofloxacin 120 0 ± 1.023.0 ± 1.0NA
Tetracycline 3033 0 ± 3.0RNA
Table 4. Summary statistics of the genomes of Streptomyces isolates. Number of biosynthetic gene clusters is based on antiSMASH analysis.
Table 4. Summary statistics of the genomes of Streptomyces isolates. Number of biosynthetic gene clusters is based on antiSMASH analysis.
IsolateSize (Mb)Contig NumbersContig N50 (Kb)Longest Contig (Kb)Biosynthetic Gene Clusters
McG26.91211899.070.725
McG38.72058623.6125.639
McG57.026107911.870.727
McG66.87415247.362.224
McG77.14346526.082.912
McG87.30465318.362.712
Table 5. Biosynthetic gene cluster (BGC) similarities between Streptomyces isolates and known antimicrobial synthesis genes. The biosynthetic gene clusters are hyperlinked to their corresponding matches in the Minimum Information about a Biosynthetic Gene cluster (MIBiG) repository. Abbreviation: Streptomyces griseus polycyclic tetramate macrolactam (SGR PTM). * Streptomyces sp. McG1 [14].
Table 5. Biosynthetic gene cluster (BGC) similarities between Streptomyces isolates and known antimicrobial synthesis genes. The biosynthetic gene clusters are hyperlinked to their corresponding matches in the Minimum Information about a Biosynthetic Gene cluster (MIBiG) repository. Abbreviation: Streptomyces griseus polycyclic tetramate macrolactam (SGR PTM). * Streptomyces sp. McG1 [14].
Gene ClusterSharedBGC Data LinkStreptomyces Isolates McG
1 *235678
Cypemycin77%BGC0000582_c1
Candicidin A66%BGC0000034_c1
Griseochelin84%BGC0001821_c1
SGR_PTMs83%BGC0001043_c1
Cyslabdan81%BGC0001910_c1
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Quinn, G.A.; Abdelhameed, A.M.; Banat, A.M.; Alharbi, N.K.; Baker, L.M.; Castro, H.C.; Dyson, P.J.; Facey, P.D.; Cobice, D.; Terra, L.; et al. Streptomyces Isolates from the Soil of an Ancient Irish Cure Site, Capable of Inhibiting Multi-Resistant Bacteria and Yeasts. Appl. Sci. 2021, 11, 4923. https://doi.org/10.3390/app11114923

AMA Style

Quinn GA, Abdelhameed AM, Banat AM, Alharbi NK, Baker LM, Castro HC, Dyson PJ, Facey PD, Cobice D, Terra L, et al. Streptomyces Isolates from the Soil of an Ancient Irish Cure Site, Capable of Inhibiting Multi-Resistant Bacteria and Yeasts. Applied Sciences. 2021; 11(11):4923. https://doi.org/10.3390/app11114923

Chicago/Turabian Style

Quinn, Gerry A., Alyaa M. Abdelhameed, Aiya M. Banat, Nada K. Alharbi, Laura M. Baker, Helena Carlo Castro, Paul J. Dyson, Paul D. Facey, Diego Cobice, Luciana Terra, and et al. 2021. "Streptomyces Isolates from the Soil of an Ancient Irish Cure Site, Capable of Inhibiting Multi-Resistant Bacteria and Yeasts" Applied Sciences 11, no. 11: 4923. https://doi.org/10.3390/app11114923

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop